,214 Preliminary peripheral and tumor analyses revealed the presence of MAGE-A4 engineered T cell immune cells in the circulation up to 18 months after treatment, elevated levels of IFN-γ up to 12 days after T cell infusion, and intra-tumoral T cell infiltration. This evidence concerns the gene MAGEA4 and neoplasm.